Statistical analysis of Cmax values < LOQ [General Sta­tis­tics]

posted by Dr_Dan  – Germany, 2010-09-30 11:52 (5743 d 19:49 ago) – Posting: # 5965
Views: 7,624

Dear all
I totally agree with ElMaestro

❝ It is not clear what the purpose of the trial is but I am willing to bet a monthly salary on the fact that the study report when reviewed by an assessor will not do much for you, whatever you do.


According to guideline CPMP/QWP/EWP/1401/98 Rev. 1 "The lower limit of quantitation should be 1/20 of Cmax or lower". If you can not detect any plasma levels in 40% of your subjects the you will have on the one hand a drug with a high inter-subject variability and on the other hand an analytical method which is not sensitive enough to cover the whole range of plasma concentrations. This is the most critical point and you will not convince any assessor with a statistical evaluation when your analytical method is not suitable except you can show that you had 40% of non-compliers.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
126 visitors (0 registered, 126 guests [including 27 identified bots]).
Forum time: 07:42 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5